Summary
Methotrexate polyglutamates are extensively synthesized when cultured hepatocytes and H35 hepatoma cells are exposed to micro-molar concentrations of methotrexate. The predominant species found within the cell have from two to four additional γ-linked glutamate residues. When either cell type containing a mixture of methotrexate and its polyglutamate derivatives is exposed to medium lacking methotrexate, there is a rapid release of methotrexate. This release has a (math) of 2 to 4 min and is apparently complete within 30 to 60 min. Methotrexate polyglutamates leave the cells much more slowly and appear to do so by two mechanisms. Although cleavage to methotrexate and subsequent efflux appears to be quantitatively the more important pathway, there is also a slow, finite loss of intact methotrexate polyglutamates from cells which exclude trypan blue. The T1/2 for the loss of methotrexate polyglutamates by both cell types, when placed in medium lacking methotrexate, is approximately 6 to 8 hr. These results, together with those of an earlier study (Galivan, J. (1980) Mol. Pharmacol. 17: 105–110), suggest that the polyglutamate derivatives are forms of methotrexate which are as cytotoxic as methotrexate but which offer a potentially greater capacity for cellular destruction because they are retained longer in the tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baugh CM, Krumdieck CL and Nair MG (1973) Biochem. Biophys. Res. Commun. 52:27–34.
Covey JM (1980) Life Soi. 26:665–678.
Jacobs SA, Adamson RH, Chabner BA, Derr CJ and Johns DG (1975) Biochen. Biophys. Res. Commun. 63:692–698.
Whitehead VM (1977) Cancer Res. 37:408–412.
Galivan J (1980) Mol. Pharmacol. 17:105–110.
Schilsky RL, Bailey BD and Chabner BA (1980) Proc. Natl. Acad. Sci. 77:2919–2922.
Goldman ID (1977) Cancer Treat. Rep. 61:549–558.
Sirotnak FM (1980) Pharmac. Ther. 8:71 – 103.
Galivan J (1979) In Chemistry and Biology of Pteridines, Kisliuk RL and Brown GM (eds) Vol. 4, pp. 543–548, Elsevier, New York.
Galivan J (1979) Res. Commun. Chem. Pathol. Pharmcol. 24:571–582.
Galivan J, Tarentino A and Samsonoff W (1980) Ann. N.Y. Acad. Sci. 349:332–345.
Tarentino AL and Galivan J (1980) .In Vitro 16:833–846.
Galivan J (1979) Cancer Res. 39:735–743.
Galivan J (1980) Arch. Biochem. Biophys. 206:113–121.
Galivan J (1981) Cancer Res. 41: 1757–1762.
Balinska M, Galivan J and Coward JK (1981) Cancer Res. 41:2751–2756.
Galivan J (1981) Exp. Cell Res. 131:379–385.
Laishes BA and Williams GM (1976) In Vitro 12: 821–832.
Miller MR, Casteilot JJ, Jr. and Pardee AB (1978) Biochemistry 17:1073–1078.
Poser RG, Sirotnak FM and Chello PL (1980) Biochem. Pharmacol. 22:2701–2704.
Yalowich JC, Fry DW and Goldman ID (1981) Proceed. Amer. Assoc. Cancer Res. 22:207.
Jolivet J, Schilsky RL and Chabner BA (1981) Proceed. Amer. Assoc. Cancer Res. 22:229.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Galivan, J., Balinska, M. (1983). Studies of Formation and Efflux of Methotrexate Polyglutamates with Cultured Hepatic Cells. In: Goldman, I.D., Chabner, B.A., Bertino, J.R. (eds) Folyl and Antifolyl Polyglutamates. Advances in Experimental Medicine and Biology, vol 163. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5241-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5241-0_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5243-4
Online ISBN: 978-1-4757-5241-0
eBook Packages: Springer Book Archive